Last Updated: May 21, 2026

Claims for Patent: 9,522,165

✉ Email this page to a colleague

Summary for Patent: 9,522,165

Title:	Formulation and method for the treatment of fungal nail infections
Abstract:	The present invention relates to a formulation and method for the treatment of fungal nail infections, such as those caused by Trichophyton rubrum and/or Aspergillus niger. The formulation of the invention comprises glucose oxidase, D-glucose and hydrogen peroxide in an aqueous solution. Advantageously, the formulation of the invention provides a two-stage hydrogen peroxide release for the treatment of the fungal nail infections.
Inventor(s):	John Reginald Barrett, James Joseph Brennan, Thomas Patrick Patton
Assignee:	INSTITUTE OF Tech SLIGO
Application Number:	US13/732,509

Details for Patent 9,522,165

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Corza Medical Gmbh	TACHOSIL	fibrin sealant patch	Patch	125351	April 05, 2010	⤷ Start Trial	2033-01-02
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,522,165

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	200902992	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2008041218	⤷ Start Trial
United States of America	9522177	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.